Published online before print July 3, 2003, doi: 10.1161/01.RES.0000084381.86567.08
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 American Heart Association, Inc.
UltraRapid Communications |
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
From the Vascular Biology Unit, Department of Surgical Research (J.E.C., P.N., S.S., C.J.G., R.F., R.M.), Northwick Park Institute for Medical Research, Harrow, Middlesex, UK; Department of Chemistry (T.R.J., B.E.M.), University of Sheffield, Sheffield, UK.
Correspondence to Dr Roberto Motterlini, Vascular Biology Unit, Department of Surgical Research, Northwick Park Institute for Medical Research, Harrow, Middlesex HA1 3UJ, UK. E-mail r.motterlini{at}imperial.ac.uk
Carbon monoxide, which is generated in mammals during the degradation of heme by the enzyme heme oxygenase, is an important signaling mediator. Transition metal carbonyls have been recently shown to function as carbon monoxide–releasing molecules (CO-RMs) and to elicit distinct pharmacological activities in biological systems. In the present study, we report that a water-soluble form of CO-RM promotes cardioprotection in vitro and in vivo. Specifically, we found that tricarbonylchloro(glycinato)ruthenium(II) (CORM-3) is stable in water at acidic pH but in physiological buffers rapidly liberates CO in solution. Cardiac cells pretreated with CORM-3 (10 to 50 µmol/L) become more resistant to the damage caused by hypoxia-reoxygenation and oxidative stress. In addition, isolated hearts reperfused in the presence of CORM-3 (10 µmol/L) after an ischemic event displayed a significant recovery in myocardial performance and a marked and significant reduction in cardiac muscle damage and infarct size. The cardioprotective effects mediated by CORM-3 in cardiac cells and isolated hearts were totally abolished by 5-hydroxydecanoic acid, an inhibitor of mitochondrial ATP-dependent potassium channels. Predictably, cardioprotection is lost when CORM-3 is replaced by an inactive form (iCORM-3) that is incapable of liberating CO. Using a model of cardiac allograft rejection in mice, we also found that treatment of recipients with CORM-3 but not iCORM-3 considerably prolonged the survival rate of transplanted hearts. These data corroborate the notion that transition metal carbonyls could be used as carriers to deliver CO and highlight the bioactivity and potential therapeutic features of CO-RMs in the mitigation of cardiac dysfunction. The full text of this article is available online at http://www.circresaha.org.
Key Words: transition metal carbonyls • carbon monoxide–releasing molecules • myocardial ischemia • heart transplantation • reperfusion injury
This article has been cited by other articles:
 |
|
 |
|
  J. Megias, M. I. Guillen, A. Bru, F. Gomar, and M. J. Alcaraz The Carbon Monoxide-Releasing Molecule Tricarbonyldichlororuthenium(II) Dimer Protects Human Osteoarthritic Chondrocytes and Cartilage from the Catabolic Actions of Interleukin-1{beta} J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 56 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L'Abbate, D. Neglia, C. Vecoli, M. Novelli, V. Ottaviano, S. Baldi, R. Barsacchi, A. Paolicchi, P. Masiello, G. S. Drummond, et al. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3532 - H3541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Urquhart, G. Rosignoli, D. Cooper, R. Motterlini, and M. Perretti Carbon Monoxide-Releasing Molecules Modulate Leukocyte-Endothelial Interactions under Flow J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 656 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bolognesi, D. Sacerdoti, A. Piva, M. Di Pascoli, F. Zampieri, S. Quarta, R. Motterlini, P. Angeli, C. Merkel, and A. Gatta Carbon Monoxide-Mediated Activation of Large-Conductance Calcium-Activated Potassium Channels Contributes to Mesenteric Vasodilatation in Cirrhotic Rats J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 187 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Ryter, D. Morse, and A. M. K. Choi Carbon Monoxide and Bilirubin: Potential Therapies for Pulmonary/Vascular Injury and Disease Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Bani-Hani, D. Greenstein, B. E. Mann, C. J. Green, and R. Motterlini Modulation of Thrombin-Induced Neuroinflammation in BV-2 Microglia by Carbon Monoxide-Releasing Molecule 3 J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1315 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bak, I. Lekli, B. Juhasz, N. Nagy, E. Varga, J. Varadi, R. Gesztelyi, G. Szabo, L. Szendrei, I. Bacskay, et al. Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1329 - H1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chlopicki, R. Olszanecki, E. Marcinkiewicz, M. Lomnicka, and R. Motterlini Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase Cardiovasc Res, July 15, 2006; 71(2): 393 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sawle, J. Hammad, I. J. S. Fairlamb, B. Moulton, C. T. O'Brien, J. M. Lynam, A. K. Duhme-Klair, R. Foresti, and R. Motterlini Bioactive Properties of Iron-Containing Carbon Monoxide-Releasing Molecules J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 403 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Foresti, S. Bains, F. Sulc, P. J. Farmer, C. J. Green, and R. Motterlini The Interaction of Nitric Oxide with Distinct Hemoglobins Differentially Amplifies Endothelial Heme Uptake and Heme Oxygenase-1 Expression J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Cohen, X.-M. Yang, and J. M. Downey Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies Cardiovasc Res, May 1, 2006; 70(2): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hill-Kapturczak and A. Agarwal Carbon monoxide: from silent killer to potential remedy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F787 - F788. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Abuarqoub, R. Foresti, C. J. Green, and R. Motterlini Heme oxygenase-1 mediates the anti-inflammatory actions of 2'-hydroxychalcone in RAW 264.7 murine macrophages Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1092 - C1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tayem, T. R. Johnson, B. E. Mann, C. J. Green, and R. Motterlini Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule Am J Physiol Renal Physiol, April 1, 2006; 290(4): F789 - F794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Taille, J. El-Benna, S. Lanone, J. Boczkowski, and R. Motterlini Mitochondrial Respiratory Chain and NAD(P)H Oxidase Are Targets for the Antiproliferative Effect of Carbon Monoxide in Human Airway Smooth Muscle J. Biol. Chem., July 8, 2005; 280(27): 25350 - 25360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vera, J. R. Henegar, H. A. Drummond, J. M. Rimoldi, and D. E. Stec Protective Effect of Carbon Monoxide-Releasing Compounds in Ischemia-Induced Acute Renal Failure J. Am. Soc. Nephrol., April 1, 2005; 16(4): 950 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Foresti, M. Hoque, D. Monti, C. J. Green, and R. Motterlini Differential Activation of Heme Oxygenase-1 by Chalcones and Rosolic Acid in Endothelial Cells J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 686 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fujimoto, M. Ohno, S. Ayabe, H. Kobayashi, N. Ishizaka, H. Kimura, K.-i. Yoshida, and R. Nagai Carbon Monoxide Protects Against Cardiac Ischemia--Reperfusion Injury In Vivo via MAPK and Akt--eNOS Pathways Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1848 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tongers, B. Fiedler, D. Konig, T. Kempf, G. Klein, J. Heineke, T. Kraft, S. Gambaryan, S. M Lohmann, H. Drexler, et al. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes Cardiovasc Res, August 15, 2004; 63(3): 545 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guo, A. B. Stein, W.-J. Wu, W. Tan, X. Zhu, Q.-H. Li, B. Dawn, R. Motterlini, and R. Bolli Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1649 - H1653. [Abstract] [Full Text] [PDF]
|
|